Literature DB >> 25657871

Deep brain light stimulation effects on glutamate and dopamine concentration.

Jinn-Rung Kuo1, Shih-Shian Lin2, Janelle Liu3, Shih-How Chen2, Chung-Chin Chio4, Jhi-Joung Wang5, Jia-Ming Liu6.   

Abstract

Compared to deep brain electrical stimulation, which has been applied to treating pathological brain diseases, little work has been done on the effect of deep brain light stimulation. A fiber-coupled laser stimulator at 840 nm wavelength and 130 Hz pulse repetition rate is developed in this work for deep brain light stimulation in a rat model. Concentration changes in glutamate and dopamine in the striatum are observed using a microdialysis probe when the subthalamic nucleus (STN) is stimulated at various optical power levels. Experimental results show that light stimulation causes the concentration of glutamate to decrease while that of dopamine is increased. This suggests that deep brain light stimulation of the STN is a promising therapeutic strategy for dopamine-related diseases such as Parkinson's disease. The stimulator developed for this work is useful for deep brain light stimulation in biomedical research.

Entities:  

Keywords:  (170.0170) Medical optics and biotechnology; (170.1420) Biology; (170.1610) Clinical applications; (170.3660) Light propagation in tissues; (170.3890) Medical optics instrumentation; (170.5180) Photodynamic therapy

Year:  2014        PMID: 25657871      PMCID: PMC4317125          DOI: 10.1364/BOE.6.000023

Source DB:  PubMed          Journal:  Biomed Opt Express        ISSN: 2156-7085            Impact factor:   3.732


  24 in total

1.  High frequency stimulation of the subthalamic nucleus evokes striatal dopamine release in a large animal model of human DBS neurosurgery.

Authors:  Young-Min Shon; Kendall H Lee; Stephan J Goerss; In Yong Kim; Chris Kimble; Jamie J Van Gompel; Kevin Bennet; Charles D Blaha; Su-Youne Chang
Journal:  Neurosci Lett       Date:  2010-03-27       Impact factor: 3.046

Review 2.  Role of low-level laser therapy in neurorehabilitation.

Authors:  Javad T Hashmi; Ying-Ying Huang; Bushra Z Osmani; Sulbha K Sharma; Margaret A Naeser; Michael R Hamblin
Journal:  PM R       Date:  2010-12       Impact factor: 2.298

Review 3.  Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.

Authors:  Christopher G Goetz; Werner Poewe; Olivier Rascol; Cristina Sampaio
Journal:  Mov Disord       Date:  2005-05       Impact factor: 10.338

Review 4.  Dopamine/glutamate interactions in Parkinson's disease.

Authors:  K W Lange; J Kornhuber; P Riederer
Journal:  Neurosci Biobehav Rev       Date:  1997-07       Impact factor: 8.989

5.  Effect of electrical and chemical stimulation of the subthalamic nucleus on the release of striatal dopamine.

Authors:  Jorge H Pazo; Cristian Höcht; Ana C Barceló; Bárbara Fillipini; María J Lomastro
Journal:  Synapse       Date:  2010-12       Impact factor: 2.562

6.  What contributes to quality of life in patients with Parkinson's disease?

Authors:  A Schrag; M Jahanshahi; N Quinn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-09       Impact factor: 10.154

7.  Glutathione is involved in the granular storage of dopamine in rat PC 12 pheochromocytoma cells: implications for the pathogenesis of Parkinson's disease.

Authors:  B Drukarch; C A Jongenelen; E Schepens; C H Langeveld; J C Stoof
Journal:  J Neurosci       Date:  1996-10-01       Impact factor: 6.167

8.  Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease.

Authors:  P Limousin; P Krack; P Pollak; A Benazzouz; C Ardouin; D Hoffmann; A L Benabid
Journal:  N Engl J Med       Date:  1998-10-15       Impact factor: 91.245

9.  Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1).

Authors:  Yair Lampl; Justin A Zivin; Marc Fisher; Robert Lew; Lennart Welin; Bjorn Dahlof; Peter Borenstein; Bjorn Andersson; Julio Perez; Cesar Caparo; Sanja Ilic; Uri Oron
Journal:  Stroke       Date:  2007-04-26       Impact factor: 7.914

10.  Glutamatergic Synaptic Dysfunction and Obsessive-Compulsive Disorder.

Authors:  Jonathan T Ting; Guoping Feng
Journal:  Curr Chem Genomics       Date:  2008-01-01
View more
  3 in total

Review 1.  Enabling biodegradable functional biomaterials for the management of neurological disorders.

Authors:  Dingying Shan; Chuying Ma; Jian Yang
Journal:  Adv Drug Deliv Rev       Date:  2019-06-20       Impact factor: 15.470

Review 2.  The Evolution of Neuroprosthetic Interfaces.

Authors:  Dayo O Adewole; Mijail D Serruya; James P Harris; Justin C Burrell; Dmitriy Petrov; H Isaac Chen; John A Wolf; D Kacy Cullen
Journal:  Crit Rev Biomed Eng       Date:  2016

3.  Immediate Evaluation of the Effect of Infrared LED Photobiomodulation on Childhood Sleep Bruxism: A Randomized Clinical Trial.

Authors:  Fernanda Yukie Kobayashi; Paula Midori Castelo; Fabiano Politti; Monise Mendes Rocha; Rafael Zaratin Beltramin; Mônica Da Consolação Canuto Salgueiro; Marcela Leticia Leal Gonçalves; Samir Nammour; Aldo Brugnera Júnior; Ravana Angelini Sfalcin; Sandra Kalil Bussadori
Journal:  Life (Basel)       Date:  2022-06-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.